K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung

Abstract

The presence of K-ras point mutations defines a subgroup of patients with lung adenocarcinoma in whom the prognosis is very poor and disease-free survival is not usually long despite radical resection and a small tumor load.